The drugs would still not be FDA-approved, and the FDA would still not vouch for their safety or effectiveness. Koehl Robinson, founder and CEO of CeliaRX, a telehealth company that sells injectable and topical peptides compounded by a 503A pharmacy partner (not the ones on the FDAs potential unbanned list), says that if the peptides are reclassified, it would likely open up new possibilities for her customers, as well as lead to more clarity and less confusion

Technical Specifications Compound: Glycyl-L-Histidyl-L-Lysine Copper Complex (GHK-Cu) Format: Lyophilized peptide powder Strength: 50 mg per vial Purity: 9899% (COA included) Appearance: Blue-tinted lyophilized powder Category: Research peptide reagent Intended Use This product is intended solely for: Laboratory experimentation Controlled in-vitro research Molecular and biochemical pathway studies Metal-peptide interaction research Non-human preclinical modeling Academic and institutional scientific projects Not intended for: Human or animal consumption Injection, ingestion, inhalation, topical, or cosmetic use Medical, therapeutic, or dermatological applications This material is not approved by Health Canada, FDA, or any regulatory body for clinical or cosmetic use
Epithalon and Gene Expression Beyond telomerase, Epithalon appears to interact with the promoter regions of several genes in cell culture research, with reported influences on transcriptional activity
combining them in one injection is meant to engage the full repair sequence at once and may produce a more consistent response